title: Isoxazole functionalization technologies enable construction of tetracycline derivatives.
authors: Scynexis, Inc. P. O. Box 12878, Research Triangle Park, NC 27709-2878, USA. brian.heasley@scynexis.com
authors: Brian
authors: B
authors: Heasley
mesh_terms: D000900:Anti-Bacterial Agents / Q000138:chemical synthesis*; D001688:Biological Products / Q000138:chemical synthesis*; D006576:Heterocyclic Compounds, 4 or More Rings / Q000138:chemical synthesis*
chemical_list: D000900:Anti-Bacterial Agents; D001688:Biological Products; D006576:Heterocyclic Compounds, 4 or More Rings